Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Venlalic XL 37.5mg tablets
0403040W0BNADAM
|
Venlalic | Venlafaxine | Central Nervous System | 1,593 |
|
Venlablue XL 37.5mg capsules
0403040W0BRACAS
|
Venlablue | Venlafaxine | Central Nervous System | 1,378 |
|
Venaxx XL 150mg capsules
0403040W0BLABAE
|
Venaxx | Venlafaxine | Central Nervous System | 1,242 |
|
Efexor XL 225mg capsules
0403040W0BBAFAT
|
Efexor | Venlafaxine | Central Nervous System | 1,233 |
|
Venaxx XL 75mg capsules
0403040W0BLAAAD
|
Venaxx | Venlafaxine | Central Nervous System | 1,029 |
|
Venlafaxine 75mg/5ml oral solution sugar free
0403040W0AAAXAX
|
Venlafaxine | Venlafaxine | Central Nervous System | 644 |
|
ViePax XL 150mg tablets
0403040W0BIABAK
|
Viepax | Venlafaxine | Central Nervous System | 421 |
|
Depefex XL 75mg capsules
0403040W0BVAAAD
|
Depefex | Venlafaxine | Central Nervous System | 411 |
|
Depefex XL 150mg capsules
0403040W0BVABAE
|
Depefex | Venlafaxine | Central Nervous System | 410 |
|
ViePax XL 75mg tablets
0403040W0BIAAAJ
|
Viepax | Venlafaxine | Central Nervous System | 375 |
|
Venladex XL 225mg tablets
0403040W0BZACAL
|
Venladex | Venlafaxine | Central Nervous System | 341 |
|
Venlafaxine 37.5mg/5ml oral solution sugar free
0403040W0AAAWAW
|
Venlafaxine | Venlafaxine | Central Nervous System | 334 |
|
Venladex XL 75mg tablets
0403040W0BZABAJ
|
Venladex | Venlafaxine | Central Nervous System | 227 |
|
Venlalic XL 300mg tablets
0403040W0BNAEAV
|
Venlalic | Venlafaxine | Central Nervous System | 178 |
|
Venlafaxine 75mg/5ml oral solution
0403040W0AAAQAQ
|
Venlafaxine | Venlafaxine | Central Nervous System | 157 |
|
Venzip XL 150mg capsules
0403040W0CEABAE
|
Venzip | Venlafaxine | Central Nervous System | 130 |
|
Sunveniz XL 75mg tablets
0403040W0BXAAAJ
|
Sunveniz | Venlafaxine | Central Nervous System | 100 |
|
Venlasov XL 75mg capsules
0403040W0CDAAAD
|
Venlasov | Venlafaxine | Central Nervous System | 98 |
|
Venzip XL 75mg capsules
0403040W0CEAAAD
|
Venzip | Venlafaxine | Central Nervous System | 93 |
|
Sunveniz XL 150mg tablets
0403040W0BXABAK
|
Sunveniz | Venlafaxine | Central Nervous System | 82 |
|
Venladex XL 150mg tablets
0403040W0BZAAAK
|
Venladex | Venlafaxine | Central Nervous System | 81 |
|
Venlafaxine 75mg/5ml oral suspension
0403040W0AAARAR
|
Venlafaxine | Venlafaxine | Central Nervous System | 56 |
|
Venlasov XL 150mg capsules
0403040W0CDABAE
|
Venlasov | Venlafaxine | Central Nervous System | 42 |
|
Venlafaxine 37.5mg/5ml oral solution
0403040W0AAANAN
|
Venlafaxine | Venlafaxine | Central Nervous System | 30 |
|
Alventa XL 150mg capsules
0403040W0BTABAE
|
Alventa | Venlafaxine | Central Nervous System | 20 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.